Article

HORMONE EXPOSURE AND VENOUS THROMBOEMBOLISM IN COMMERCIALLY-INSURED WOMEN 50 TO 64 YEARS OF AGE

2022-11-20

Abstract excerpt

<h4>Objective</h4> Determine whether hormone-associated venous thromboembolism (VTE) risk varies by exposure route and formulation in 50-64 year-old US women. <h4>Design</h4> Nested case-control study. <h4>Setting</h4> Large US commercially-insured population with patient-level claims data. <h4>Participants</h4> Women aged 50-64 years with at least one year of enrollment. Controls were matched to incident cases (1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e73a60e-05ef-56d7-a83d-bd7dd4f51919
DOI: 10.1101/2022.11.19.22282547

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HORMONE EXPOSURE AND VENOUS THROMBOEMBOLISM IN COMMERCIALLY-INSURED WOMEN 50 TO 64 YEARS OF AGEDOI 10.1101/2022.11.19.22282547Read

Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.Semantic proximity Read

Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk.Semantic proximity Read

Oral contraceptives, hormone therapy and cardiovascular risk.Semantic proximity Read

Risk factors for venous thromboembolism in pre-and postmenopausal women.Semantic proximity Read

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review.Semantic proximity Read

Integrating Pharmacokinetic, Pharmacogenomic, and Clinical Risk Data to Individualise Hormonal Contraception and Minimise Thrombotic Risk: A Translational Framework.Semantic proximity Read

Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read

The genetic effects of hormones modulated by the Pituitary-Thyroid/Adrenal/Gonadal axis on the risk of developing venous thromboembolism: a mendelian randomization study.Semantic proximity Read

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.Semantic proximity Read

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.Semantic proximity Read

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read

Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH study.Semantic proximity Read